{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:44:56Z","timestamp":1780983896411,"version":"3.54.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.gastrohep.2010.02.006","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T02:19:49Z","timestamp":1272853189000},"page":"41-52","source":"Crossref","is-referenced-by-count":9,"title":["Colangitis esclerosante primaria: diagn\u00f3stico, pron\u00f3stico y tratamiento"],"prefix":"10.1016","volume":"34","author":[{"given":"Albert","family":"Par\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2010.02.006_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.510300101","article-title":"Primary sclerosing cholangitis","volume":"30","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib2","first-page":"644","article-title":"[Sclerosing cholangitis caused by formol in the treatment of hydatid cyst of the liver]","volume":"9","author":"Bourgeon","year":"1985","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib3","first-page":"297","article-title":"[Sclerosing cholangitis secondary to an accidental injection of chlorhexidine (Mercryl(R)) into the biliary tract: A case report]","volume":"26","author":"Inacio","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib4","first-page":"441","article-title":"[Sclerosing cholangitis with papillary stenosis in an HIV-infected patients with Cryptosporidium infection]","volume":"32","author":"Jablonowski","year":"1994","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib7","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: A population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"Ang","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib12","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3748\/wjg.14.3350","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"14","author":"Chapman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199006283222603","article-title":"Association of primary sclerosing cholangitis with HLA-DRw52a","volume":"322","author":"Prochazka","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/gut.33.7.942","article-title":"HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: No HLA-DRw52a association in Swedish patients with sclerosing cholangitis","volume":"33","author":"Zetterquist","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","article-title":"Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis","volume":"16","author":"Farrant","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.1840130119","article-title":"Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-8278(99)80068-3","article-title":"Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis","volume":"30","author":"Bernal","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/gast.2001.24041","article-title":"Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: The role of MICA polymorphism","volume":"120","author":"Norris","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/jhep.2001.27543","article-title":"Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles","volume":"34","author":"Wiencke","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2003.11.009","article-title":"Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1","volume":"40","author":"Yang","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib23","first-page":"875","article-title":"Detection of Helicobacter in the liver of patients with chronic cholestatic liver diseases","volume":"50","author":"Nilsson","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00042737-200206000-00009","article-title":"A survey of infectious agents as risk factors for primary sclerosing cholangitis: Are Chlamydia species involved?","volume":"14","author":"Ponsioen","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib25","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840130425","article-title":"Biliary tract disease in rats with experimental small bowel bacterial overgrowth","volume":"13","author":"Lichtman","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","article-title":"BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Pauli-Magnus","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1572-0241.2005.41072.x","article-title":"Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis","volume":"100","author":"Gallegos-Orozco","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","article-title":"Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis","volume":"113","author":"Sheth","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0168-8278(02)00161-7","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis","volume":"37","author":"Girodon","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/bega.2001.0207","article-title":"Animal models for primary sclerosing cholangitis","volume":"15","author":"Vierling","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib32","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib34","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0016-5085(90)91096-O","article-title":"Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease","volume":"98","author":"Porayko","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/jhep.2002.31872","article-title":"Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis","volume":"35","author":"Boberg","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib37","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib38","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3748\/wjg.14.3781","article-title":"Autoantibodies in primary sclerosing cholangitis","volume":"14","author":"Hov","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.149.1.6412283","article-title":"Primary sclerosing cholangitis: Findings on cholangiography and pancreatography","volume":"149","author":"MacCarty","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: Its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib43","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00281-009-0167-2","article-title":"Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"31","author":"Borchers","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib48","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: A long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broome","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib51","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0168-8278(02)00085-5","article-title":"Small duct primary sclerosing cholangitis","volume":"36","author":"Chapman","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/bega.2001.0213","article-title":"Sclerosing cholangitis in the paediatric patient","volume":"15","author":"Mieli-Vergani","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib54","first-page":"1415","article-title":"Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis","volume":"22","author":"Wilschanski","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(99)00603-0","article-title":"Sclerosing pancreato-cholangitis responsive to steroid therapy","volume":"354","author":"Erkelens","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/00365520600664326","article-title":"Autoimmune pancreatocholangitis: A series of ten patients","author":"Van Buuren","year":"2006","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib57","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature","volume":"45","author":"Bjornsson","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib59","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","article-title":"Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis","volume":"45","author":"Zen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib60","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: Clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0399-8320(07)89323-7","article-title":"Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: A retrospective study of 115 cases of autoimmune liver disease","volume":"31","author":"Heurgue","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib62","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib63","first-page":"31","article-title":"Autoimmune sclerosing cholangitis: An overlap syndrome in a child","volume":"18","author":"Gopal","year":"1999","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib64","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib65","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/jhep.2002.37200","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib66","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib68","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.510290607","article-title":"The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis","volume":"29","author":"Kim","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib69","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/jlts.2000.18485","article-title":"Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score","volume":"6","author":"Talwalkar","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib70","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.510250501","article-title":"The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis","volume":"25","author":"Shetty","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib72","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/jhep.2003.50289","article-title":"Primary sclerosing cholangitis in children: A long-term follow-up study","volume":"38","author":"Feldstein","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1091-255X(99)80051-1","article-title":"Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis","volume":"3","author":"Ahrendt","year":"1999","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib74","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1111\/j.1572-0241.2007.01220.x","article-title":"Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis","volume":"102","author":"Bjornsson","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib75","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0168-8278(00)80386-4","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development","volume":"32","author":"Boberg","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib76","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib77","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: Risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib78","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib81","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.510280316","article-title":"Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography","volume":"28","author":"Keiding","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib82","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11605-007-0345-2","article-title":"Primary sclerosing cholangitis: Detection of cancer in strictures","volume":"12","author":"Schulick","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib83","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0168-8278(99)80198-6","article-title":"A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"30","author":"Hultcrantz","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib84","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.1840120421","article-title":"Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study in 65 patients with bile duct strictures","volume":"12","author":"Rabinovitz","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-1999-18","article-title":"Value of brush cytology for dominant strictures in primary sclerosing cholangitis","volume":"31","author":"Ponsioen","year":"1999","journal-title":"Endoscopy"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib86","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib87","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib88","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib89","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib90","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hep.20370","article-title":"Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis","volume":"40","author":"Rost","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib91","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib92","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib93","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: A 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib94","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","article-title":"Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study","volume":"14","author":"O\u2019Brien","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","article-title":"Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period","volume":"20","author":"Stiehl","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib96","first-page":"1472","article-title":"Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period","volume":"43","author":"De Mar\u00eda","year":"1996","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-8278(98)80059-7","article-title":"Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses","volume":"29","author":"Van Hoogstraten","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib98","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1590-8658(03)00076-8","article-title":"Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: Results of a retrospective Italian multicentre survey","volume":"35","author":"Okolicsanyi","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib99","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib100","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib101","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib102","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(71)80107-1","article-title":"Azathioprine treatment in primary sclerosing cholangitis","volume":"2","author":"Wagner","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040423","article-title":"Medical approaches to primary sclerosing cholangitis","volume":"11","author":"Kaplan","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib104","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(95)90220-1","article-title":"Colchicine treatment of primary sclerosing cholangitis","volume":"108","author":"Olsson","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib105","first-page":"57","article-title":"The combination of prednisone and colchicine in patients with primary sclerosing cholangitis","volume":"86","author":"Lindor","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib106","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/0016-5085(88)90180-1","article-title":"Prospective trial of penicillamine in primary sclerosing cholangitis","volume":"95","author":"LaRusso","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib107","first-page":"CD004182","article-title":"D-penicillamine for primary sclerosing cholangitis","author":"Klingenberg","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib108","first-page":"455","article-title":"Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: Results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib109","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7326\/0003-4819-106-2-231","article-title":"Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response.","volume":"106","author":"Kaplan","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib111","first-page":"546","article-title":"Treatment of primary sclerosing cholangitis with oral methotrexate","volume":"86","author":"Knox","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib112","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis","volume":"106","author":"Knox","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib113","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","article-title":"A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis","volume":"95","author":"Bharucha","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib114","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1026673811278","article-title":"Oral nicotine in treatment of primary sclerosing cholangitis: A pilot study","volume":"44","author":"Angulo","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib115","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s10620-007-0052-6","article-title":"Silymarin in the treatment of patients with primary sclerosing cholangitis: An open-label pilot study","volume":"53","author":"Angulo","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib116","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2004.02214.x","article-title":"A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis","volume":"20","author":"Sterling","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib117","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib118","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","article-title":"Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study","volume":"26","author":"Stiehl","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: Outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2006-933564","article-title":"Primary sclerosing cholangitis: The role of endoscopic therapy","volume":"26","author":"Stiehl","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib121","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1572-0241.2001.03696.x","article-title":"Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: The Mayo Clinic experience","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib122","article-title":"Antibiotics for the treatment of primary sclerosing cholangitis","author":"Elfaki","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib123","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/hep.510290210","article-title":"Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography","volume":"29","author":"Berr","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib124","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/jlts.2003.50169","article-title":"Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list","volume":"9","author":"Brandsaeter","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-933565","article-title":"Liver transplantation in primary sclerosing cholangitis","volume":"26","author":"Bjoro","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib127","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: A long-term clinicopathologic study","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib128","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: A magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment","volume":"12","author":"Par\u00e9s","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.gastrohep.2010.02.006_bib131","doi-asserted-by":"crossref","unstructured":"Par\u00e9s A, Herrera M, Aviles J, Sanz M, Mas A. Treatment of resistant pruritus of cholestasis with albumin dialysis. Combined analysis of patients from three centers. J Hepatol 2010 (en prensa).","DOI":"10.1016\/j.jhep.2010.02.031"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570510000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570510000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:39:59Z","timestamp":1559068799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570510000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0210570510000518"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2010.02.006","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}